Reference of 66127-01-3, Because a catalyst decreases the height of the energy barrier, its presence increases the reaction rates of both the forward and the reverse reactions by the same amount.66127-01-3, Name is 3-Bromo-1,10-phenanthroline, molecular formula is C12H7BrN2. In a article，once mentioned of 66127-01-3
Three novel Cd(II) complexes, formulated as [Cd(3,8-dibromo-1,10-phen-kappa2N,N?)(l-tar)]n (1), trans-[Cd(3,8-dibromo-1,10-phen-kappa2N,N?)2(NO3-kappa2O,O?)2]·(CH3CN) (2) and cis-[Cd(3,6-dibromo-1,10-phen-kappa2N,N?)(3-bromo-1,10-phen-kappa2N,N?)(NO3-2O,O?)(CH3OH-kappaO)](NO3) (3) (phen = phenanthroline, l-tarH2 = l-tartaric acid), have been synthesized and characterized in this paper. In coordination polymer 1, the [Cd2(3,8-dibromo-phen)2]4+ cations are bridged by l-tar ligands into an infinite 2D lamellar polymer along the c-axis, and the neighboring 2D polymers are further extended into a 3D supramolecular network by pi-pi stacking interactions. Complexes 2 and 3 are both mononuclear cadmium complexes but with different conformation (trans or cis). In the crystal packing structures of 2 and 3, molecules are arranged into three-dimensional (3D) frameworks by intermolecular hydrogen bonding and pi-pi stacking interactions.
We’ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 66127-01-3, and how the biochemistry of the body works.Reference of 66127-01-3
Reference：
Metal catalyst and ligand design,
Ligand Template Strategies for Catalyst Encapsulation – NCBI